<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18270558</PMID><DateCompleted><Year>2008</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>2</Issue><PubDate><Year>2008</Year><Month>Feb</Month><Day>13</Day></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Higher infection of dengue virus serotype 2 in human monocytes of patients with G6PD deficiency.</ArticleTitle><Pagination><StartPage>e1557</StartPage><MedlinePgn>e1557</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1557</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0001557</ELocationID><Abstract><AbstractText>The prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency is high in Asia. An ex vivo study was conducted to elucidate the association of G6PD deficiency and dengue virus (DENV) infection when many Asian countries are hyper-endemic. Human monocytes from peripheral mononuclear cells collected from 12 G6PD-deficient patients and 24 age-matched controls were infected with one of two DENV serotype 2 (DENV-2) strains-the New Guinea C strain (from a case of dengue fever) or the 16681 strain (from a case of dengue hemorrhagic fever) with a multiplicity of infection of 0.1. The infectivity of DENV-2 in human monocytes was analyzed by flow cytometry. Experimental results indicated that the monocytes of G6PD-deficient patients exhibited a greater levels of infection with DENV-2 New Guinea C strain than did those in healthy controls [mean+/-SD:33.6%+/-3.5 (27.2% approximately 39.2%) vs 20.3%+/-6.2 (8.0% approximately 30.4%), P&lt;0.01]. Similar observations were made of infection with the DENV-2 16681 strain [40.9%+/-3.9 (35.1% approximately 48.9%) vs 27.4%+/-7.1 (12.3% approximately 37.1%), P&lt;0.01]. To our knowledge, this study demonstrates for the first time higher infection of human monocytes in G6PD patients with the dengue virus, which may be important in increasing epidemiological transmission and perhaps with the potential to develop more severe cases pathogenically.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chao</LastName><ForeName>Yuan-Chang</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University (NTU), Taipei, Taiwan, Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Ching-Shan</ForeName><Initials>CS</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Chun-Nan</ForeName><Initials>CN</Initials></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Sui-Yuan</ForeName><Initials>SY</Initials></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Chwan-Chuen</ForeName><Initials>CC</Initials></Author><Author ValidYN="Y"><LastName>Kao</LastName><ForeName>Chuan-Liang</ForeName><Initials>CL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2008</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005955" MajorTopicYN="N">Glucosephosphate Dehydrogenase Deficiency</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019595" MajorTopicYN="N">Severe Dengue</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2007</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2008</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>2</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>7</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>2</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18270558</ArticleId><ArticleId IdType="pmc">PMC2216061</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0001557</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11:480&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC88892</ArticleId><ArticleId IdType="pubmed">9665979</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol. 2002;10:100&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">11827812</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubler DJ. The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle? Comp Immunol Microbiol Infect Dis. 2004;27:319&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pubmed">15225982</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott RM, Nisalak A, Cheamudon U, Seridhoranakul S, Nimmannitya S. Isolation of dengue viruses from peripheral blood leukocytes of patients with hemorrhagic fever. J Infect Dis. 1980;141:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">7365271</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YC, Wang SY, King CC. Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism. J Virol. 1999;73:2650&#x2013;2657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC104020</ArticleId><ArticleId IdType="pubmed">10074110</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho LJ, Wang JJ, Shaio MF, Kao CL, Chang DM, Han SW, Lai JH. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J Immunol. 2001;166:1499&#x2013;1506.</Citation><ArticleIdList><ArticleId IdType="pubmed">11160189</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev Infect Dis 11 Suppl. 1989;4:S830&#x2013;S839.</Citation><ArticleIdList><ArticleId IdType="pubmed">2665015</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeves EP, Lu H, Jacobs HL, Messina CG, Bolsover S, Gabella G, Potma EO, Warley A, Roes J, Segal AW. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature. 2002;416:291&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pubmed">11907569</ArticleId></ArticleIdList></Reference><Reference><Citation>Beutler E. G6PD deficiency. Blood. 1994;84:3613&#x2013;3636.</Citation><ArticleIdList><ArticleId IdType="pubmed">7949118</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta A, Mason PJ, Vulliamy TJ. Glucose-6-phosphate dehydrogenase deficiency. Baillieres Best Pract Res Clin Haematol. 2000;13:21&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">10916676</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Working Group. Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ. 1989;67:601&#x2013;611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2491315</ArticleId><ArticleId IdType="pubmed">2633878</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwai K, Hirono A, Matsuoka H, Kawamoto F, Horie T, Lin K, Tantular IS, Dachlan YP, Notopuro H, Hidayah NI, Salim AM, Fujii H, Miwa S, Ishii A. Distribution of glucose-6-phosphate dehydrogenase mutations in Southeast Asia. Hum Genet. 2001;108:445&#x2013;449.</Citation><ArticleIdList><ArticleId IdType="pubmed">11499668</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang SH, Wu SJ, Wu KF, Hsiao KJ. Neonatal screening for glucose-6-phosphate dehydrogenase deficiency in Taiwan. Southeast Asian J Trop Med Public Health 30 Suppl. 1999;2:72&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">11400791</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamlok RJ, Mamlok V, Mills GC, Daeschner CW, III, Schmalstieg FC, Anderson DC. Glucose-6-phosphate dehydrogenase deficiency, neutrophil dysfunction and Chromobacterium violaceum sepsis. J Pediatr. 1987;111:852&#x2013;854.</Citation><ArticleIdList><ArticleId IdType="pubmed">3681551</ArticleId></ArticleIdList></Reference><Reference><Citation>Vives Corrons JL, Feliu E, Pujades MA, Cardellach F, Rozman C, Carreras A, Jou JM, Vallespi MT, Zuazu FJ. Severe-glucose-6-phosphate dehydrogenase (G6PD) deficiency associated with chronic hemolytic anemia, granulocyte dysfunction, and increased susceptibility to infections: description of a new molecular variant (G6PD Barcelona). Blood. 1982;59:428&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">7055648</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotsman I, Muszkat M. Glucose-6-phosphate dehydrogenase deficiency is associated with increased initial clinical severity of acute viral hepatitis A. J Gastroenterol Hepatol. 2001;16:1239&#x2013;1243.</Citation><ArticleIdList><ArticleId IdType="pubmed">11903742</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray GR, Stamatoyannopoulos G, Naiman SC, Kliman MR, Klebanoff SJ, Austin T, Yoshida A, Robinson GC. Neutrophil dysfunction, chronic granulomatous disease, and non-spherocytic haemolytic anaemia caused by complete deficiency of glucose-6-phosphate dehydrogenase. Lancet. 1973;2:530&#x2013;534.</Citation><ArticleIdList><ArticleId IdType="pubmed">4125296</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Osba YK, Mallouh AA, Hann RW. Incidence and causes of sepsis in glucose-6-phosphate dehydrogenase-deficient newborn infants. J Pediatr. 1989;114:748&#x2013;752.</Citation><ArticleIdList><ArticleId IdType="pubmed">2715888</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa E, Vasconcelos J, Santos E, Laranjeira A, Castro e Melo, Barbot J. Neutrophil dysfunction in a case of glucose-6-phosphate dehydrogenase deficiency. J Pediatr Hematol Oncol. 2002;24:164&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">11990707</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanphaichitr VS, Chonlasin R, Suwantol L, Pung-Amritt P, Tachavanich K, Yogsan S, Viprakasit V. Effect of red blood cell glucose-6-phosphate dehydrogenase deficiency on patients with dengue hemorrhagic fever. J Med Assoc Thai. 2002;85(Suppl 2):S522&#x2013;S529.</Citation><ArticleIdList><ArticleId IdType="pubmed">12403228</ArticleId></ArticleIdList></Reference><Reference><Citation>King CC, Wu YC, Chao DY, Lin TH, Lin C, Wang HT, Ku CC, Kao CL, Chien LJ, Chang HJ, Huang JH, Twu SJ, Huang KP, Lam SK, Gubler DJ. Major Epidemics of Dengue in Taiwan in 1981&#x2013;2000: Related to Intensive Virus Activities in Asia in 1981&#x2013;2000: Related to Intensive Virus Activities in Asia. Dengue Bulletin. 2000;24:1&#x2013;10.</Citation></Reference><Reference><Citation>Wang WK, Chao DY, Kao CL, Wu HC, Liu YC, Li CM, Lin SC, Ho ST, Huang JH, King CC. High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology. 2003;305:330&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">12573578</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes JM, Rigau-Perez JG, Reiter P, Effler PV, Pang L, Vorndam V, Hinten SR, Mark KE, Myers MF, Street K, Bergau L, Meyer C, Amador M, Napier M, Clark GG, Biggerstaff BJ, Gubler DJ. Risk factors for infection during a dengue-1 outbreak in Maui, Hawaii, 2001. Trans R Soc Trop Med Hyg. 2006;100:559&#x2013;566.</Citation><ArticleIdList><ArticleId IdType="pubmed">16356519</ArticleId></ArticleIdList></Reference><Reference><Citation>van Bruggen R, Bautista JM, Petropoulou T, de Boer M, van Zwieten R, Gomez-Gallego F, Belohradsky BH, Hartwig NG, Stevens D, Mason PJ, Roos D. Deletion of leucine 61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood. 2002;100:1026&#x2013;1030.</Citation><ArticleIdList><ArticleId IdType="pubmed">12130518</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TP, Roberts RL, Wu KG, Ank BJ, Stiehm ER. Decreased superoxide anion and hydrogen peroxide production by neutrophils and monocytes in human immunodeficiency virus-infected children and adults. Pediatr Res. 1993;34:544&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pubmed">8255691</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindgren H, Stenmark S, Chen W, Tarnvik A, Sjostedt A. Distinct roles of reactive nitrogen and oxygen species to control infection with the facultative intracellular bacterium Francisella tularensis. Infect Immun. 2004;72:7172&#x2013;7182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC529105</ArticleId><ArticleId IdType="pubmed">15557642</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J, Lee KJ, Zheng Y, Yamaga AK, Lai MM, Ou JH. Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells. Hepatology. 2004;39:81&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">14752826</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan WH, Helt AM, Maranon C, Barbaroux JB, Hosmalin A, Harris E, Fridman WH, Mueller CG. Dendritic cell precursors are permissive to dengue virus and human immunodeficiency virus infection. J Virol. 2005;79:7291&#x2013;7299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1143643</ArticleId><ArticleId IdType="pubmed">15919883</ArticleId></ArticleIdList></Reference><Reference><Citation>LaFleur C, Granados J, Vargas-Alarcon G, Ruiz-Morales J, Villarreal-Garza C, Higuera L, Hernandez-Pacheco G, Cutino-Moguel T, Rangel H, Figueroa R, Acosta M, Lazcano E, Ramos C. HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever. Hum Immunol. 2002;63:1039&#x2013;1044.</Citation><ArticleIdList><ArticleId IdType="pubmed">12392857</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CS, Chang PF, Huang MJ, Chen ES, Chen WC. Glucose-6-phosphate dehydrogenase deficiency, the UDP-glucuronosyl transferase 1A1 gene and neonatal hyperbilirubinemia. Gastroenterology. 2002;123:127&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">12105841</ArticleId></ArticleIdList></Reference><Reference><Citation>Kung CM, King CC, Lee CN, Huang LM, Lee PI, Kao CL. Differences in replication capacity between enterovirus 71 isolates obtained from patients with encephalitis and those obtained from patients with herpangina in Taiwan. J Med Virol. 2007;79:60&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">17133556</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao CL, Wu MC, Chiu YH, Lin JL, Wu YC, Yueh YY, Chen LK, Shaio MF, King CC. Flow cytometry compared with indirect immunofluorescence for rapid detection of dengue virus type 1 after amplification in tissue culture. J Clin Microbiol. 2001;39:3672&#x2013;3677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC88405</ArticleId><ArticleId IdType="pubmed">11574589</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>